By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pluristem Therapeutics 



New York  New York    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Pluristem Therapeutics (PSTI) To Present At The International Congress Of Radiation Research And Chair Two Panels At The Annual Meeting Of The International Society For Cellular Therapy 5/27/2015 7:58:49 AM
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 5/26/2015 6:42:58 AM
Pluristem Therapeutics (PSTI) To Conduct Conference At Tel Aviv Stock Exchange To Review Regulatory Progress And Company Strategy 5/19/2015 10:44:34 AM
Significant Progress For Pluristem Therapeutics (PSTI): PLX Cells Were Selected For European Medicines Agency's Adaptive Pathways Pilot Project 5/18/2015 10:21:20 AM
Pluristem Therapeutics (PSTI)'s PLX Cells One Step Closer To Entering Japan's Accelerated Pathway For Regenerative Medicine 5/13/2015 12:54:40 PM
Pluristem Therapeutics (PSTI) To Hold Symposium On Therapeutic Angiogenesis For Peripheral Arterial Occlusive Disease At European Society For Vascular Medicine In Berlin, Germany 5/7/2015 12:39:12 PM
Pluristem Therapeutics (PSTI) To Present At Five Industry And Finance Conferences In May 5/4/2015 10:56:22 AM
Pluristem Therapeutics (PSTI)'s Clinical Advisory Board Prepares Phase II Clinical Trials In Critical Limb Ischemia In Europe And Japan 4/20/2015 7:41:25 AM
Celgene (CELG), Mesoblast (MSB.AX) $45M Deal "Speaks Volumes" About Big Pharma's Cell Therapy Plans, Says Pluristem Therapeutics (PSTI) 4/14/2015 6:27:36 AM
Pluristem Therapeutics (PSTI) Announces Key Strategic Objectives For Development Of PLX-R18 In Hematopoietic Indications 3/24/2015 7:24:19 AM
12345678910...
//-->